CAPS Plus: A Clinical Biomarker Scoring System to Predict Aβ Positivity and Facilitate Enrollment in Anti-Amyloid Clinical Trials

CAPS Plus is potentially a useful screening tool for enrollment in anti-Aβ therapy and clinical trials for AD, specifically addressing people with prodromal and mild AD.

Authors

Publication Details

Journal
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
Published
2026-01-20
DOI
https://doi.org/10.1017/cjn.2026.10530
Primary Topic
Amyloidosis: Diagnosis, Treatment, Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

CAPS Plus: A Clinical Biomarker Scoring System to Predict Aβ Positivity and Facilitate Enrollment in Anti-Amyloid Clinical Trials

Carlos Roncero, Cheryl L. Wellington, Durjoy Lahiri, Jennifer G. Cooper et al.
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
Amyloidosis: Diagnosis, Treatment, Outcomes
article

CAPS Plus: A Clinical Biomarker Scoring System to Predict Aβ Positivity and Facilitate Enrollment in Anti-Amyloid Clinical Trials

Carlos Roncero, Cheryl L. Wellington, Durjoy Lahiri, Jennifer G. Cooper, Bruna Seixas-Lima, Howard Chertkow
article en

Abstract

CAPS Plus is potentially a useful screening tool for enrollment in anti-Aβ therapy and clinical trials for AD, specifically addressing people with prodromal and mild AD.

Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
Openalex Percentile: Top 84%
Amyloidosis: Diagnosis, Treatment, Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

CAPS Plus: A Clinical Biomarker Scoring System to Predict Aβ Positivity and Facilitate Enrollment in Anti-Amyloid Clinical Trials — Carlos Roncero, Cheryl L. Wellington, et al. · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques (2026) | TGRS Research Map | TGRS